نمایش مختصر رکورد

dc.contributor.authorMirmohammadi, Seyedeh Taherehen_US
dc.contributor.authorEghbali, Samiraen_US
dc.contributor.authorMohammadparast-Tabas, Pouriaen_US
dc.contributor.authorYousefi, Masouden_US
dc.date.accessioned1403-12-20T23:06:44Zfa_IR
dc.date.accessioned2025-03-10T23:06:44Z
dc.date.available1403-12-20T23:06:44Zfa_IR
dc.date.available2025-03-10T23:06:44Z
dc.date.issued2024-08-01en_US
dc.date.issued1403-05-11fa_IR
dc.identifier.citation(1403). مجله علمي دانشگاه علوم پزشكي بيرجند, 31(2), 127-139. doi: 10.61186/JBUMS.31.2.127fa_IR
dc.identifier.issn16072197
dc.identifier.issn2423-6152
dc.identifier.urihttps://dx.doi.org/10.61186/JBUMS.31.2.127
dc.identifier.urihttp://journal.bums.ac.ir/article-1-3394-en.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/1132780
dc.description.abstractBackground and Aims: The increase in the incidence of antimicrobial resistance in pathogens has led researchers to identify new and effective antimicrobial agents. Green production of nanoparticles has received attention due to its compatibility with the environment and low cost. The present study sought to characterize and evaluate the antibacterial activities of silver nanoparticles synthesized with Plantago lanceolata seed extract. Materials and Methods: In this study, after the synthesis of silver nanoparticles by chemical and green methods, the characteristics of silver nanoparticles synthesized with the P. lanceolata seed extract were evaluated by UV-Vis, DLS, XRD, FT-IR, and TEM methods. Thereafter, the optimal conditions for the synthesis of nanoparticles and the antibacterial activity of the P. lanceolata extract, chemical silver nanoparticles, and green silver nanoparticles against standard bacterial strains were investigated by determining the minimum inhibitory concentration (MIC) using the broth microdilution method. Results: Based on the absorption spectrum of green silver nanoparticles with UV-Vis, the optimal concentration of silver nitrate was 20 mM, the suitable synthesis temperature was 57 °C, and the best reaction time was reported as 30 sec. The results of XRD, FT-IR, and TEM analyses confirmed the synthesis of green silver nanoparticles with oval and spherical morphology with a size of 20-40 nm. The P. lanceolata extract and chemical silver nanoparticles had no significant antibacterial effect. Nonetheless, green silver nanoparticles had significant antibacterial activity on the studied bacteria, with the highest antibacterial effect against Staphylococcus aureus and Enterococcus faecalis (MIC=125 μg/mL). Conclusion: As evidenced by the obtained results, P. lanceolata seed extract significantly increased the antibacterial activity of silver nanoparticles. This research demonstrated the potential of environmentally friendly silver nanoparticles synthesized in the presence of P. lanceolata extract with significant antibacterial effects for various biomedical applications.en_US
dc.languageEnglish
dc.language.isoen_US
dc.publisherدانشگاه علوم پزشکی بیرجندfa_IR
dc.relation.ispartofمجله علمي دانشگاه علوم پزشكي بيرجندfa_IR
dc.relation.ispartofJournal of Birjand University of Medical Sciencesen_US
dc.relation.isversionofhttps://dx.doi.org/10.61186/JBUMS.31.2.127
dc.subjectSilver nanoparticleen_US
dc.subjectP. lanceolata seed extracaAntibacterial agentsen_US
dc.subjectBiosynthesisen_US
dc.subjectP. lanceolataen_US
dc.subjectSilver nanoparticlesten_US
dc.subjectGreen synthesisen_US
dc.subjectAntibacterial effectsen_US
dc.subjectMicrobiologyen_US
dc.titleCharacterization and evaluation of the antibacterial activities of silver nanoparticle synthesized with Plantago lanceolata seed extracten_US
dc.typeTexten_US
dc.typeOriginal Articleen_US
dc.contributor.departmentStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iranen_US
dc.contributor.departmentDepartment of Pharmacognosy and Traditional Pharmacy, School of Pharmacy, Birjand University of Medical Sciences, Birjand, Iranen_US
dc.contributor.departmentStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iranen_US
dc.contributor.departmentDepartment of Medical Microbiology, School of Medicine, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iranen_US
dc.citation.volume31
dc.citation.issue2
dc.citation.spage127
dc.citation.epage139


فایل‌های این مورد

فایل‌هااندازهقالبمشاهده

فایلی با این مورد مرتبط نشده است.

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد